http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2040919-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75eb7f802d18764aa3b7c9c2aad351d8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 1993-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8615095fbadf3ace3b8168474e098e9 |
| publicationDate | 1995-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2040919-C1 |
| titleOfInvention | Method for treating malignant neoplastic changes in eye |
| abstract | FIELD: medicine. SUBSTANCE: method involves dissecting the prominent part of the tumor, applying cryogenic destruction in one-treatment procedure by exposing the tumor twice with 3 min pause to a temperature of -160 (-100) C during 50-70 s with the following daily beta therapy one day later to be done within 3-7 days. EFFECT: enhanced effectiveness of treatment. 1 tbl |
| priorityDate | 1993-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4022878 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451856544 |
Total number of triples: 16.